Foghorn Hosted Virtual Investor Event Information Title: Pipeline Updates for Selective ARID1B, Selective CBP and Selective EP300 Degrader Programs Date/Time: Thursday, October 30, 2025 at 12 p.m. EDT ...
For Europe to compete globally, biotech investment must grow. MEP Tomislav Sokol and Amgen’s Gilles Marrache discuss what ...
Strasbourg, France-based EVerZom, a biotechnology company specialised in exosome-based therapies for regenerative medicine ...
Funds for two of the nation’s largest infrastructure projects, the Second Avenue subway and Hudson River tunnels, are being held up in apparent attempts to pressure Democrats amid a government ...
Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a new class of medicines that treat serious diseases by ...
CureVac's (CVAC) mRNA innovations, strong patent portfolio, and investment potential. Learn the risks and rewards of this biotech stock.
EVerZom raises €10M to develop exosome-based biotherapies for inflammatory diseases. Through this funding round, the company will initiate the clinical developmen ...
There isn’t a “No” Committee listed in the Pierce County voter’s guide for this measure. At Orting High School, there are ...
Registration for JEE Main 2026, one of India's most important engineering admission exams, will open on the NTA's schedule.
Hyderabad is the Pharma Hub of India. It is home to top pharmaceutical companies, Genome Valley, and Pharma City. Discover ...
Nepal urgently needs a National Department of Biotechnology to unify fragmented research efforts, support local talent and ...